As of 2025-11-21, the Relative Valuation of Paratek Pharmaceuticals Inc (PRTK) is (17.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.23 USD, the upside of Paratek Pharmaceuticals Inc based on Relative Valuation is -881.6%.
The range of the Relative Valuation is (16.39) - (18.71) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 17.1x | 14.8x |
| Forward P/E multiples | 15.0x - 20.4x | 17.0x |
| Fair Price | (16.39) - (18.71) | (17.43) |
| Upside | -835.2% - -939.2% | -881.6% |
| Date | P/E |